SOURCE: Nanosphere

October 29, 2013 10:38 ET

Nanosphere to Release Third Quarter 2013 Results and Hold Investor Conference Call on Wednesday, November 6, 2013

NORTHBROOK, IL--(Marketwired - Oct 29, 2013) -  Nanosphere, Inc. (NASDAQ: NSPH), a company enhancing medicine through targeted molecular diagnostics, today announced that it will report its results for the third quarter of 2013 before the market opens on Wednesday, November 6, 2013. The company will also hold a live investor conference call and webcast at 10:00am Eastern/7:00am Pacific.

Conference Call & Webcast
Wednesday, November 6, 2013 @ 10:00am Eastern Time/7:00am Pacific Time
Domestic: 888-778-8914
International: 913-312-0693
Passcode: 3630719
Webcast: www.nanosphere.us

Replays - Available through November 20, 2013
Domestic: 877-870-5176
International: 858-384-5517
Passcode: 3630719

About Nanosphere, Inc.

Nanosphere is enhancing medicine through targeted molecular diagnostics that result in earlier disease detection, optimal patient treatment and improved healthcare economics. The Company's versatile technology platform, the Verigene® System, enables clinicians to rapidly detect the most complex, costly and deadly infectious diseases through a low cost and simple-to-use multiplexed diagnostic test. The combination of this innovative technology and Nanosphere's customer-driven solutions keeps commitment to the patient at the forefront of its business. Nanosphere is based in Northbrook, IL. Additional information is available at http://www.nanosphere.us.

Except for historical information, the matters discussed in this press release are "forward-looking statements" and are subject to risks and uncertainties. Actual results could differ materially from these forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, the following: (i) Nanosphere's ability to develop commercially viable products; (ii) Nanosphere's ability to achieve profitability; (iii) Nanosphere's ability to produce and market its products; (iv) Nanosphere's ability to obtain regulatory approval of its products; (v) Nanosphere's ability to protect its intellectual property; (vi) competition and alternative technologies; and (vii) Nanosphere's ability to obtain additional financing to support its operations. Additional risks are discussed in the Company's current filings with the Securities and Exchange Commission. Although the Company believes the expectations reflected in such forward-looking statements are based on reasonable assumptions, it can give no assurance that its expectations will be attained. The forward-looking statements are made as of the date of this press release, and we undertake no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.

Contact Information